Delivery Order SPE2D021DA002-SPE2D325F110Z
- Not listed
- On August 28, 2025, the Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a firm fixed-price delivery order valued at $2,093.62 to DMS Pharmaceutical Group Inc. for the supply of Isentress 400 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of August 29, 2025. This delivery order was issued without a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,280.86 on August 18, 2025, for the supply of Isentress 400 mg tablets (60-count units). This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation. The award represents a continuation of DMS...
- This federal contract award, valued at $13,811.70, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Isentress 400 mg tablets, with a completion date of June 25, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,905.85 firm fixed-price contract is for the supply of Isentress 400 mg tablets, with a period of performance through March 29, 2024. The award is issued under DMS Pharmaceutical Group's $4,999,999 indefinite delivery contract SPE2DB, which enables the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,381.17 firm fixed-price contract is for the supply of ISENTRESS 400 MG tablets, and has a completion date of June 3, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,381.17, is for the delivery of Isentress 400 mg tablets. This order is part of a larger indefinite delivery contract, SPE2DB, that DMS Pharmaceutical Group holds with DLA, valued up to $4,999,999 through 2025. Through this IDV, DMS Pharmaceutical provides a wide...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $9,238.18 and covers the delivery of the pharmaceutical product Isentress 400 mg tablets. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs, over-the-counter...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Isentress 400 mg tablets. The contract, valued at $1,381.17, has an ultimate completion date of April 30, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive...
- The U.S. Defense Logistics Agency, operating through the Medical Supply Chain division, awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for $2,093.62 on September 29, 2025. The order covers 60 tablets of Isentress 400 mg, an antiretroviral medication used in HIV treatment, with delivery to Park Ridge, Illinois and a completion deadline of September 30, 2025. This delivery order was issued without a set-aside designation, leveraging the vendor's status as a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,650.54 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of ISENTRESS 100 MG TABLET CHEW UU 60S, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F110ZDelivery Order
This delivery order, valued at $1,429.30, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Isentress 400 mg tablets (60-count units). The award was issued on June 6, 2025, under a firm fixed-price contract type with an ultimate completion date of June 11, 2025. The product will be delivered to Park Ridge, Illinois, and the contract was funded by the Defense Logistics Agency's Medical Supply Chain division. This delivery order was not issued under any set-aside designation. DMS Pharmaceutical Group secured this award under its larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency valued at $499,999,999 through November 2026. As a woman-owned small business registered in the System for Award Management since 2001, the company serves as a significant pharmaceutical distributor to Department of Defense healthcare facilities nationwide, supplying prescription medications, biologics, and medical consumables across multiple therapeutic categories. The SPE2DB program vehicle enables the Defense Logistics Agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical support to military medical installations worldwide, and DMS Pharmaceutical Group's established position as a qualified supplier underscores its critical role in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/6/25 |